(Q54731291)

English

Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14757324

Decreased cerebrospinal fluid neuropeptide Y (NPY) in patients with treatment refractory unipolar major depression: preliminary evidence for association with preproNPY gene polymorphism. (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14757324

cerebrospinal fluid

0 references

1

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14757324

Annika Thorsell

3

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14757324

7

object named as

Marie Asberg

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14757324

Magnus Sjögren

6

object named as

Magnus Sjögren

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14757324

Salim Mottagui-Tabar

5

object named as

Salim Mottagui-Tabar

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14757324

author name string

Olof Zachrisson

2

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14757324

Anna Ehnvall

4

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14757324

Rolf Ekman

8

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14757324

Claes Wahlestedt

9

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14757324

Hans Agren

10

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14757324

publication date

1 March 2004

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14757324

Journal of Psychiatric Research

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14757324

38

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14757324

2

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14757324

113-121

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14757324

Low levels of somatostatin in human CSF mark depressive episodes

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Neuropeptide Y promotes sleep and inhibits ACTH and cortisol release in young men.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Neurotransmitters and suicidal behavior. The evidence from cerebrospinal fluid studies

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

CSF monoamine metabolites in melancholia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Cerebrospinal fluid neuropeptides in mood disorder and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Cerebrospinal fluid neuropeptide Y in depression and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Cerebrospinal fluid monoamine metabolites in 114 healthy individuals 18-88 years of age

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Reduced neuropeptide Y mRNA expression in the prefrontal cortex of subjects with bipolar disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Alterations in neuropeptide Y levels and Y1 binding sites in the Flinders Sensitive Line rats, a genetic animal model of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Novel neuropeptide Y processing in human cerebrospinal fluid from depressed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Hamilton Depression Rating Scale. Extracted from Regular and Change Versions of the Schedule for Affective Disorders and Schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

A diagnostic interview: the schedule for affective disorders and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Neuropeptides and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Antisense inhibition of neuropeptide Y (NPY)-Y1 receptor expression blocks the anxiolytic-like action of NPY in amygdala and paradoxically increases feeding.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Corticotropin-releasing factor and neuropeptide Y: role in emotional integration

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Cerebrospinal fluid neuropeptides in Alzheimer's disease and vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Centrally administered neuropeptide Y (NPY) produces anxiolytic-like effects in animal anxiety models

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Brain neuropeptide Y (NPY) in stress and alcohol dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Dynamic allele-specific hybridization. A new method for scoring single nucleotide polymorphisms

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Involvement of hippocampal neuropeptide Y in mediating the chronic actions of lithium, electroconvulsive stimulation and citalopram

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Altered intracellular processing and release of neuropeptide Y due to leucine 7 to proline 7 polymorphism in the signal peptide of preproneuropeptide Y in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Association of a leucine(7)-to-proline(7) polymorphism in the signal peptide of neuropeptide Y with high serum cholesterol and LDL cholesterol levels

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

The neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Neuropeptide Y polymorphism and alcohol consumption in middle-aged men

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Effect of a selective neuropeptide Y Y(2) receptor antagonist, BIIE0246 on neuropeptide Y release

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Cerebrospinal fluid immunoreactive somatostatin concentrations in patients with Cushing's disease and major depression: relationship to indices of corticotropin-releasing hormone and cortisol secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

A functional neuropeptide Y Leu7Pro polymorphism associated with alcohol dependence in a large population sample from the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Allostasis and allostatic load: implications for neuropsychopharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

CSF monoamine metabolites and somatostatin in Alzheimer's disease and major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Decreased experimental anxiety and voluntary ethanol consumption in rats following central but not basolateral amygdala lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Neuropeptide Y in frontal cortex is not altered in major depression

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Robust and accurate single nucleotide polymorphism genotyping by dynamic allele-specific hybridization (DASH): design criteria and assay validation

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Neuropeptide Y (NPY) and depression: from animal studies to the human condition

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

CSF Somatostatin in Affective Illness

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Amygdalar neuropeptide Y Y1 receptors mediate the anxiolytic-like actions of neuropeptide Y in the social interaction test

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Effect of repeated electroconvulsive treatment on regional concentrations of tachykinins, neurotensin, vasoactive intestinal polypeptide, neuropeptide Y, and galanin in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Neuropeptide-Y exerts antidepressant-like effects in the forced swim test in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Neuropeptide Y--a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Behavioral and endocrine adaptation, and up-regulation of NPY expression in rat amygdala following repeated restraint stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Suppressed neuropeptide Y (NPY) mRNA in rat amygdala following restraint stress.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Electroconvulsive shocks increase the concentration of neocortical and hippocampal neuropeptide Y (NPY)-like immunoreactivity in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

The role of neuropeptide Y in cardiovascular regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Reduced neuropeptide Y concentrations in suicide brain

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

NPY Leu7Pro and alcohol dependence in Finnish and Swedish populations

1 reference

https://api.crossref.org/works/10.1016%2FS0022-3956%2803%2900101-8

7 January 2021

Identifiers

10.1016/S0022-3956(03)00101-8

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14757324

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 June 2018

http://europepmc.org/abstract/MED/14757324

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54731291&oldid=2028187607"